The decline in Berry Global's stock price can be attributed to the market's negative reaction to both the earnings miss and the strategic decision to spin-off and merge its Health division. Earnings misses typically lead to short-term negative price adjustments as they reflect operational challenges. Additionally, strategic moves like spin-offs and mergers, especially when unexpected, can create uncertainty among investors, further pressuring the stock price.